I am an attorney in the Division of Investment Management at the U.S. Securities and Exchange Commission in Washington, D.C. However, because the SEC requires me to get preclearance of all writings relating to the SEC or securities law prior to publication, I do not blog on anything relating to my job.
I expect many of my posts to focus on health and medicine. I became interested in medical research while researching treatment options for my teenage daughter, who has heterozygous familial hypercholesterolemia, a genetic disease that causes very high LDL-cholesterol. In addition, I am a breast cancer survivor and may blog occasionally on issues related to breast cancer. I am a member of the Society for Participatory Medicine and a Friend of the National Physicians Alliance. In addition, I am a member/administrator of the Familial Hypercholesterolemia (FH) Discussion Group on Facebook(https://www.facebook.com/#!/groups/47098836197/). As of September 2013, I became a member of the editorial board of Circulation: Cardiovascular Quality and Outcomes, one of the American Heart Association journals. In November 2013, I joined the ABIM Assessment 2020 Task Force.
Contact me at mannm at comcast.net. Follow me on Twitter @MarilynMann.
Comments without a valid email address will be deleted.
The U.S. Securities and Exchange Commission disclaims responsibility for any private publication or statement of any Commission employee or Commissioner. This blog expresses my views and does not necessarily reflect those of the Commission, the Commissioners, or other members of the staff.